282 related articles for article (PubMed ID: 17181426)
21. [Clinical aspects of epileptic ion channel disorders].
Campos-Castelló J; Canelón de López M; García-Fernández M
Rev Neurol; 2000 Jun; 30 Suppl 1():S42-6. PubMed ID: 10904967
[TBL] [Abstract][Full Text] [Related]
22. A novel inherited mutation in the voltage sensor region of SCN1A is associated with Panayiotopoulos syndrome in siblings and generalized epilepsy with febrile seizures plus.
Livingston JH; Cross JH; Mclellan A; Birch R; Zuberi SM
J Child Neurol; 2009 Apr; 24(4):503-8. PubMed ID: 19339291
[TBL] [Abstract][Full Text] [Related]
23. Translational research in epilepsy genetics: sodium channels in man to interneuronopathy in mouse.
Mullen SA; Scheffer IE
Arch Neurol; 2009 Jan; 66(1):21-6. PubMed ID: 19139296
[TBL] [Abstract][Full Text] [Related]
24. Susceptibility genes in human epilepsy.
Leppert MF; Singh N
Semin Neurol; 1999; 19(4):397-405. PubMed ID: 10716662
[TBL] [Abstract][Full Text] [Related]
25. [Epilepsy and genetics].
Picard F
Rev Med Suisse Romande; 2003 May; 123(5):317-21. PubMed ID: 15095716
[TBL] [Abstract][Full Text] [Related]
26. Genetics of epilepsies.
Andrade DM; Minassian BA
Expert Rev Neurother; 2007 Jun; 7(6):727-34. PubMed ID: 17563254
[TBL] [Abstract][Full Text] [Related]
27. [New epileptic syndromes].
Serratosa JM
Neurologia; 1999 May; 14 Suppl 3():20-4. PubMed ID: 10379163
[TBL] [Abstract][Full Text] [Related]
28. Channelopathies can cause epilepsy in man.
Steinlein OK
Eur J Pain; 2002; 6 Suppl A():27-34. PubMed ID: 11888238
[TBL] [Abstract][Full Text] [Related]
29. Patients with a sodium channel alpha 1 gene mutation show wide phenotypic variation.
Osaka H; Ogiwara I; Mazaki E; Okamura N; Yamashita S; Iai M; Yamada M; Kurosawa K; Iwamoto H; Yasui-Furukori N; Kaneko S; Fujiwara T; Inoue Y; Yamakawa K
Epilepsy Res; 2007 Jun; 75(1):46-51. PubMed ID: 17507202
[TBL] [Abstract][Full Text] [Related]
30. How do mutant Nav1.1 sodium channels cause epilepsy?
Ragsdale DS
Brain Res Rev; 2008 Jun; 58(1):149-59. PubMed ID: 18342948
[TBL] [Abstract][Full Text] [Related]
31. Epilepsy with a de novo missense mutation in the sodium channel a1 subunit: a case report.
Stefanaki E; Aggelakou V; Orfanou M; Kokori E; Boutoufianakis S
Acta Paediatr; 2006 Dec; 95(12):1703-6. PubMed ID: 17129991
[TBL] [Abstract][Full Text] [Related]
32. Progress in searching for the febrile seizure susceptibility genes.
Nakayama J
Brain Dev; 2009 May; 31(5):359-65. PubMed ID: 19201561
[TBL] [Abstract][Full Text] [Related]
33. Clinical evaluation and diagnosis of severe epilepsy syndromes of early childhood.
Zupanc ML
J Child Neurol; 2009 Aug; 24(8 Suppl):6S-14S. PubMed ID: 19666878
[TBL] [Abstract][Full Text] [Related]
34. Novel de novo mutation of a conserved SCN1A amino-acid residue (R1596).
Dlugos DJ; Ferraro TN; Buono RJ
Pediatr Neurol; 2007 Oct; 37(4):303-5. PubMed ID: 17903680
[TBL] [Abstract][Full Text] [Related]
35. Mosaic SCN1A mutation in familial severe myoclonic epilepsy of infancy.
Marini C; Mei D; Helen Cross J; Guerrini R
Epilepsia; 2006 Oct; 47(10):1737-40. PubMed ID: 17054697
[TBL] [Abstract][Full Text] [Related]
36. [Clinical and genetic diagnosis of Dravet syndrome: report of 20 cases].
Siegler Z; Neuwirth M; Hegyi M; Paraicz E; Pálmafy B; Tegzes A; Barsi P; Karcagi V; Claes L; De Jonghe P; Herczegfalvi A; Fogarasi A
Ideggyogy Sz; 2008 Nov; 61(11-12):402-8. PubMed ID: 19070316
[TBL] [Abstract][Full Text] [Related]
37. Physicochemical property changes of amino acid residues that accompany missense mutations in SCN1A affect epilepsy phenotype severity.
Kanai K; Yoshida S; Hirose S; Oguni H; Kuwabara S; Sawai S; Hiraga A; Fukuma G; Iwasa H; Kojima T; Kaneko S
J Med Genet; 2009 Oct; 46(10):671-9. PubMed ID: 19586930
[TBL] [Abstract][Full Text] [Related]
38. Novel de novo splice-site mutation of SCN1A in a patient with partial epilepsy with febrile seizures plus.
Kumakura A; Ito M; Hata D; Oh N; Kurahashi H; Wang JW; Hirose S
Brain Dev; 2009 Feb; 31(2):179-82. PubMed ID: 18632234
[TBL] [Abstract][Full Text] [Related]
39. A novel locus for generalized epilepsy with febrile seizures plus in French families.
Baulac S; Gourfinkel-An I; Couarch P; Depienne C; Kaminska A; Dulac O; Baulac M; LeGuern E; Nabbout R
Arch Neurol; 2008 Jul; 65(7):943-51. PubMed ID: 18625863
[TBL] [Abstract][Full Text] [Related]
40. The role of companion diagnostics in the development and use of mutation-targeted cancer therapies.
Papadopoulos N; Kinzler KW; Vogelstein B
Nat Biotechnol; 2006 Aug; 24(8):985-95. PubMed ID: 16900147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
